home / stock / sava / sava quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2020-02-12 | 7.77 | 7.84 | 8.19 | 7.71 | 841,648 |
2020-02-11 | 8.16 | 7.85 | 8.35 | 7.69 | 2,002,736 |
2020-02-10 | 8.02 | 7.88 | 8.20 | 7.80 | 857,248 |
2020-02-07 | 8.20 | 7.90 | 8.28 | 7.86 | 1,142,888 |
2020-02-06 | 8.45 | 8.25 | 8.4625 | 8.21 | 505,137 |
2020-02-05 | 8.48 | 8.47 | 8.57 | 8.17 | 1,064,567 |
2020-02-04 | 8.95 | 8.35 | 9.00 | 8.11 | 3,794,720 |
2020-02-03 | 8.29 | 8.12 | 9.26 | 8.05 | 3,695,839 |
2020-01-31 | 7.90 | 8.15 | 8.35 | 7.84 | 851,283 |
2020-01-30 | 8.08 | 8.03 | 8.1523 | 7.61 | 1,614,660 |
2020-01-29 | 8.62 | 8.29 | 8.7578 | 8.03 | 2,168,994 |
2020-01-28 | 6.86 | 8.66 | 9.75 | 6.86 | 10,317,233 |
2020-01-27 | 6.93 | 7.15 | 7.50 | 6.80 | 1,263,790 |
2020-01-24 | 7.72 | 7.175 | 7.75 | 7.03 | 1,489,187 |
2020-01-23 | 8.02 | 7.73 | 8.08 | 7.62 | 1,113,565 |
2020-01-22 | 7.81 | 8.10 | 8.41 | 7.75 | 1,881,769 |
2020-01-21 | 7.97 | 7.89 | 8.10 | 7.84 | 1,408,719 |
2020-01-20 | 8.50 | 8.25 | 8.58 | 7.85 | 2,728,671 |
2020-01-17 | 8.50 | 8.25 | 8.58 | 7.85 | 2,709,439 |
2020-01-16 | 8.71 | 8.63 | 8.82 | 8.30 | 3,273,828 |
Cassava Sciences Inc. Company Name:
SAVA Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Royal Philips (NYSE: PHG) , Cassava Sciences (NASDAQ: SAVA) , and IDEXX Laboratories (NASDAQ: IDXX) are all worth looking into this year. All three healthcare stocks have trends working in their favor, driving share growth that far outstrips that of the S&P 500...
Are These The Best Biotech Stocks To Buy Now? Biotech stocks were one of the biggest winners in the stock market last year. While many stocks on the market have yet to recover fully from the crash in March, top biotech stocks have thrived. The SPDR S&P Biotech Index ...
AUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the appointment of James Kupiec, MD, to the newly created position of Chief Clinical Development Officer. Dr. ...